Table: Sapporo Clinical Lab -9-MTH group results

Sapporo Clinical Laboratory

09/02/2016 06:30

Feb 9 (Reuters)-  
             Sapporo Clinical Laboratory Co Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 9 months ended      9 months ended       Year to  
                Dec 31, 2015        Dec 31, 2014     Mar 31, 2016  
                   LATEST             YEAR-AGO          LATEST     
                   RESULTS             RESULTS         FORECAST    
  Sales             13.13               12.65            17.71     
                 (+3.7 pct)          (+1.4 pct)       (+3.2 pct)   
  Operating        706 mln             593 mln          834 mln    
                 (+19.0 pct)         (-18.7 pct)      (-4.0 pct)   
  Recurring        723 mln             614 mln          835 mln    
                 (+17.7 pct)         (-18.3 pct)      (-6.8 pct)   
  Net              454 mln             368 mln          532 mln    
                 (+23.5 pct)         (-15.8 pct)      (-7.1 pct)   
  EPS            130.65 yen           94.27 yen       153.15 yen   
  Ann Div                             12.00 yen        11.00 yen   
  -Q2 div            NIL                 NIL                       
  -Q4 div                             12.00 yen        11.00 yen   
   
  NOTE - Sapporo Clinical Laboratory Co Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T 
  ((Tokyo Headline News Desk +813 6441 1812))